Come up with a name for your new list and we'll add to it:
Salient Pharmaceuticals raised a round of funding on April 07, 2008. Investors include
Houston Angel Network.
Salient Pharmaceuticals is a life science company developing a proprietary compound intended for use in treating severe diarrhea associated with chemotherapy, chronic conditions, infectious diseases a…